The Clinical Handbook of Psychotropic Drugs, now in its 17th edition, has become a standard reference for thousands of psychiatrists, psychologists, physicians, nurses, and indeed virtually all categories of mental health professionals. This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs: Find clear advice about medication options and precautions Look up details of a range of treatment options in easy-to-read comparison charts Check up on the precautions needed in the young, the elderly, or pregnant patients See potential interactions and side effects at a glance And much, much more Widely regarded as the best practical guide on the market, the Clinical Handbook presents readers with reliable, easy-to-find, state-of-the-art information. With its spiral-bound horizontal page format, succinct, bulleted outline information, clearly laid out comparison charts and tables, and comprehensive index of generic and trade names - all the latest scientific data, clinical guidelines, and patient instructions are uniquely accessible. Easy to use, with succinct bulleted information on all classes of medication! Packed with uniquely practical comparison charts!
Rezensionen / Stimmen
"Packed with useful information and remarkably error-free... I recommend its purchase for use in office-based practices, as a reference on the wards, and as a ready reference and text for students" (Nicholas Delva, MD, in Can J Psychiatry) "An invaluable quick reference guide for the busy clinician." (B.E. Leonard in Human Psychopharmacol Clin Exp) "Comprehensive... clearly and consistently organized... an ideal resource for rapid and straightforward retrieval of essential clinical information... a 'must have' for those who work in mental health care." (Marshall Cates, PharmD, in Annals Pharmacother) "Should be available at all nursing stations." (C. Lindsay DeVane, PharmD, in Am J Health System Pharmacy) "Precise - concise - informative!" (Charles J. Messer, MD) "Invaluable in clinical practice as well as psychiatric research... of the highest quality... I can recommend it to any of my colleagues... an excellent teaching tool... handout sheets at the end are very helpful to patients." (Corey Goldstein, MD, Rush Presbyterian - St. Luke's Medical Center) "A very practical handbook, packed with numerous charts and tables... up-to-date and most welcome straightforward guide to psychotropic drugs... a top quality publication full of essential information and data." (Paul Shelley, in Int J Psychiatric Nursing Res) "I use it to teach psychiatry students - it is phenomenal!" (Toby Goldsmith, MD, Vanderbilt University)"
Auflage
17., überarb. u. erw. Aufl.
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für Beruf und Forschung
For Psychiatrists, psychiatric nurses, pharmacists, clinical psychologists, other mental health professionals
Editions-Typ
Illustrationen
Maße
Höhe: 21.6 cm
Breite: 28 cm
ISBN-13
978-0-88937-345-7 (9780889373457)
Schweitzer Klassifikation
Antidepressants; Selective Serotonin Reuptake Inhibitors (SSRI); Norepinephrine Dopamine Reuptake Inhibitor; (NDRI); Selective Serotonin Norepinephrine Reuptake Inhibitor (SNRI); Serotonin-2 Antagonists/Reuptake Inhibitors (SARI); Noradrenergic/Specific Serotonergic Antidepressants (NaSSA); Non-Selective Cyclic Antidepressants; Monoamine Oxidase Inhibitors; Reversible Inhibitor of MAO-A (RIMA); Irreversible Monoamine Oxidase Inhibitors; Monoamine Oxidase B Inhibitor; Effects of Antidepressants on Neurotransmitters/Receptors; Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors; Frequency of Adverse Reactions to Cyclic Antidepressants at Therapeutic Doses; Frequency (per cent) of Adverse Reactions to MAOI Antidepressants at Therapeutic Doses; Antidepressant Doses and Pharmacokinetics; Switching Antidepressants; Antidepressant Augmentation Strategies; Electroconvulsive Therapy (ECT); Bright-Light Therapy (BLT); Repetitive Transcranial Magnetic Stimulation (rTMS); Antipsychotics (Neuroleptics); "Second-Generation" Antipsychotics/SGAs (Neuroleptics); "Third-Generation" Antipsychotic/TGA (Neuroleptics); "First Generation" Antipsychotics/FGAs; Effects of Antipsychotics on Neurotransmitters/Receptors; Pharmacological Effects of Antipsychotics on Neurotransmitters/Receptors; Frequency (per cent) of Adverse Reactions to Antipsychotics at Therapeutic Doses; Antipsychotic Doses and Pharmacokinetics; Comparison of Depot Antipsychotics; Extrapyramidal Side Effects of Antipsychotics; Switching Antipsychotics; Antipsychotic Augmentation Strategies; Agents for Treating Extrapyramidal Side Effects; Effects on Extrapyramidal Symptoms; Comparison of Agents for Treating Extrapyramidal Side Effects; Anxiolytic Agents; Benzodiazepines; Comparison of the Benzodiazepines; Buspirone; Hypnotics/Sedatives; Comparison of Hypnotics/Sedatives; Mood Stabilizers; Lithium; Anticonvulsants; Comparison of Anticonvulsants; Comparison of Adverse Reactions to Mood Stabilizers at Therapeutic Doses; L-Tryptophan; Drugs for ADHD; Psychostimulants; Atomoxetine; Comparison of Drugs for ADHD; Clonidine; Augmentation Strategies in ADHD; Drugs for Treatment of Dementia; Cholinesterase Inhibitors; Memantine; Comparison of Drugs for Treatment of Dementia; Sex-Drive Depressants; Comparison of Sex-Drive Depressants; Drugs of Abuse; Alcohol; Stimulants; Hallucinogens; Opiates/Narcotics; Inhalants/Aerosols; Gamma Hydroxy Butyrate (GHB)/Sodium Oxybate; Flunitrazepam (Rohypnol); Treatment of Substance Use Disorders; Disulfiram; Acamprosate; Naltrexone; Methadone; Buprenorphine; New Unapproved Treatments of Psychiatric Disorders; Adrenergic Agents; Calcium Channel Blockers; Dopaminergic Agents; GABA-Agents/Anticonvulsants; Serotonin Antagonists; Opioid Antagonists/Agonists; Steroid Biosynthesis Inhibitors; Immunomodulators; Hormones; Miscellaneous; Herbal and "Natural" Products; Glossary; Suggested Readings; Patient Information Sheets; Index of Drugs.
